Distribution of Polymorphic Markers of Genes Encoding the Renin-angiotensin System (ACE, AGT, AGTR1), ITGB3, PPARG, Pparg in Patients With Essential Hypertension Depending on the Age
Author:
Zotova Tatyana1, Azova Madina2, Lukanina Anastasia1, Aissa A. Ait2, Blagonravov Mikhail1
Affiliation:
1. A. Frolov Department of General Pathology and Pathological Physiology, Peoples’ Friendship University of Russia (RUDN University), Institute of Medicine, 6, Miklukho-Maklaya Str., Moscow, 117198, RUSSIAN FEDERATION 2. Department of Biology and General Genetics, Peoples’ Friendship University of Russia (RUDN University), Institute of Medicine, 6, Mikukho-Maklaya Str., Moscow, 117198, RUSSIAN FEDERATION
Abstract
Essential hypertension (EH) is a multifactorial disease with a hereditary predisposition. Genes encoding the renin-angiotensin system (RAS) play a leading role in the stabilization of elevated BP in the course of EH, which determines the relevance of our clinical and genetic study. The study was based on the determination of the frequencies of polymorphic markers of the AGT, AGTR1, ACE, ITGB3, PPARG genes in 2 groups, depending on the age of patients (up to 60 years - group1, n=18, and after 60 years - group2, n=31), for the intergroup frequencies comparison and comparison of group frequencies with population data. Genotyping by gene polymorphisms was performed by real-time polymerase chain reaction. 24-hour ambulatory BP monitoring (ABPM) and Holter HR monitoring were conducted. Phenotypic features of the course of EH were accompanied by changes in the frequency characteristics of the studied genotypes. In patients of group 1, an increase in the frequency of protective genotypes of the ACE(II) and ITGB3(TT) genes was observed (p=0.004;0.015), which confirms the hypothesis of a possible favorable course of EH in patients under 60 years.
Publisher
North Atlantic University Union (NAUN)
Subject
General Biochemistry, Genetics and Molecular Biology,Biomedical Engineering,General Medicine,Bioengineering
Reference24 articles.
1. M. Singh, A. K. Singh; P. Pandey, S. Chandra, K. A. Singh, I. S. Gambhir, “Molecular genetics of essential hypertension”. Clin. Exp. Hypertens, 38(3), pp. 268- 277, 2016, doi: 10.3109/10641963.2015.1116543. 2. T. Yu. Zotova, A. P. Kubanova, M. M. Azova, Amira Aut Aissa, “Peculiarities of the clinical picture of arterial hypertension depending on polymorphic variant of AGTR1 gene”. Clinical Medicine, 95(5), pp. 404- 407, 2017, doi: http://dx.doi.org/10.18821/0023-2149- 2017-95-4-404-407. 3. M. E. Dickson, C. D. Sigmund, “Genetic basis of hypertension: revisiting angiotensinogen”. Hypertension, 48(1), pp. 14-20, 2006, doi: 10.1161/01.HYP.0000227932.13687.60. 4. O. S. Glotov, A. S. Glotov, O. A. Tarasenko, T. E. Ivaschenko, V. S. Baranov, “Analysis of ACE, AGTR1, eNOS, MTHFR, MTRR and APOE genes polymorphisms in the population of North-West of Russia”. Ecological genetics, 2, pp. 32-35, 2004, doi: 10.17816/ecogen2332-35. 5. O. S. Pavlova, S. E. Ogurtsova, M. M. Liventseva, T. H. Lakotko, I. Y. Korobko, V. I. Shyshko, A. G. Mrochek, “Association of the I/D polymorphism of angiotensinconverting enzyme gene with the development of essential hypertension”. The Siberian Journal of Clinical and Experimental Medicine, 34(3), pp. 87-96, 2019, https://doi.org/10.29001/2073-8552- 2019-34-3-87-96.
|
|